| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3942235
[patent_doc_number] => 05976845
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Composite antibodies of human subgroup IV light chain capable of binding to TAG-72'
[patent_app_type] => 1
[patent_app_number] => 8/487743
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 31
[patent_no_of_words] => 19736
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976845.pdf
[firstpage_image] =>[orig_patent_app_number] => 487743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487743 | Composite antibodies of human subgroup IV light chain capable of binding to TAG-72 | Jun 6, 1995 | Issued |
Array
(
[id] => 3996212
[patent_doc_number] => 05919910
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/477553
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 5435
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919910.pdf
[firstpage_image] =>[orig_patent_app_number] => 477553
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477553 | Monoclonal antibodies | Jun 6, 1995 | Issued |
Array
(
[id] => 4023900
[patent_doc_number] => 05993827
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins'
[patent_app_type] => 1
[patent_app_number] => 8/487826
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 43938
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/993/05993827.pdf
[firstpage_image] =>[orig_patent_app_number] => 487826
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487826 | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins | Jun 6, 1995 | Issued |
| 08/467855 | METHOD FOR THE TREATMENT OF MALIGNANCIES INVOLVING CELLS EXPRESSING MHC CLASS II ANTIGENS | Jun 5, 1995 | Abandoned |
Array
(
[id] => 3937428
[patent_doc_number] => 05976535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore'
[patent_app_type] => 1
[patent_app_number] => 8/468513
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 38600
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976535.pdf
[firstpage_image] =>[orig_patent_app_number] => 468513
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468513 | Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore | Jun 5, 1995 | Issued |
Array
(
[id] => 3730414
[patent_doc_number] => 05698201
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Method for treatment of antigenically modified polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/468716
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 48722
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698201.pdf
[firstpage_image] =>[orig_patent_app_number] => 468716
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468716 | Method for treatment of antigenically modified polypeptides | Jun 5, 1995 | Issued |
Array
(
[id] => 3704323
[patent_doc_number] => 05674982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Multimeric form of human rhinovirus receptor protein'
[patent_app_type] => 1
[patent_app_number] => 8/469588
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8851
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674982.pdf
[firstpage_image] =>[orig_patent_app_number] => 469588
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469588 | Multimeric form of human rhinovirus receptor protein | Jun 4, 1995 | Issued |
Array
(
[id] => 3630796
[patent_doc_number] => 05686582
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Multimeric forms of human rhinovirus receptor protein'
[patent_app_type] => 1
[patent_app_number] => 8/464083
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 29
[patent_no_of_words] => 15912
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686582.pdf
[firstpage_image] =>[orig_patent_app_number] => 464083
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464083 | Multimeric forms of human rhinovirus receptor protein | Jun 4, 1995 | Issued |
Array
(
[id] => 3606835
[patent_doc_number] => 05589343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes'
[patent_app_type] => 1
[patent_app_number] => 8/463512
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7384
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589343.pdf
[firstpage_image] =>[orig_patent_app_number] => 463512
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463512 | Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes | Jun 4, 1995 | Issued |
Array
(
[id] => 3630787
[patent_doc_number] => 05686581
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Multimeric form of human rhinovirus receptor protein'
[patent_app_type] => 1
[patent_app_number] => 8/469581
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8862
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686581.pdf
[firstpage_image] =>[orig_patent_app_number] => 469581
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469581 | Multimeric form of human rhinovirus receptor protein | Jun 4, 1995 | Issued |
Array
(
[id] => 3621992
[patent_doc_number] => 05602031
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 8/462062
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7457
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602031.pdf
[firstpage_image] =>[orig_patent_app_number] => 462062
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462062 | DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them | Jun 4, 1995 | Issued |
Array
(
[id] => 3933521
[patent_doc_number] => 05871733
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Multimeric forms of human rhinovirus receptor protein'
[patent_app_type] => 1
[patent_app_number] => 8/469587
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 29
[patent_no_of_words] => 15327
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871733.pdf
[firstpage_image] =>[orig_patent_app_number] => 469587
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469587 | Multimeric forms of human rhinovirus receptor protein | Jun 4, 1995 | Issued |
Array
(
[id] => 3804533
[patent_doc_number] => 05811106
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Plasmodium falciparum thrombospondin-related anonymous proteins (TRAP), fragments and functional derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/454619
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5959
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811106.pdf
[firstpage_image] =>[orig_patent_app_number] => 454619
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454619 | Plasmodium falciparum thrombospondin-related anonymous proteins (TRAP), fragments and functional derivatives | May 30, 1995 | Issued |
Array
(
[id] => 4209673
[patent_doc_number] => 06086865
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Methods of treating angiogenesis-induced diseases and pharmaceutical compositions thereof'
[patent_app_type] => 1
[patent_app_number] => 8/456280
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3802
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086865.pdf
[firstpage_image] =>[orig_patent_app_number] => 456280
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456280 | Methods of treating angiogenesis-induced diseases and pharmaceutical compositions thereof | May 30, 1995 | Issued |
Array
(
[id] => 3696064
[patent_doc_number] => 05650487
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Serum immunoregulatory polypeptides and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/455645
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650487.pdf
[firstpage_image] =>[orig_patent_app_number] => 455645
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455645 | Serum immunoregulatory polypeptides and uses therefor | May 30, 1995 | Issued |
Array
(
[id] => 3738653
[patent_doc_number] => 05800820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Methods and compositions for treatment of angiogenic diseases'
[patent_app_type] => 1
[patent_app_number] => 8/456132
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8678
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/800/05800820.pdf
[firstpage_image] =>[orig_patent_app_number] => 456132
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456132 | Methods and compositions for treatment of angiogenic diseases | May 30, 1995 | Issued |
| 08/451913 | HLA BINDING PEPTIDES AND THEIR USES | May 25, 1995 | Abandoned |
Array
(
[id] => 4001498
[patent_doc_number] => 05888519
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Encapsulated high-concentration lipid a compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections'
[patent_app_type] => 1
[patent_app_number] => 8/446174
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6791
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/888/05888519.pdf
[firstpage_image] =>[orig_patent_app_number] => 446174
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446174 | Encapsulated high-concentration lipid a compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections | May 18, 1995 | Issued |
Array
(
[id] => 3883744
[patent_doc_number] => 05833996
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Treatment of psoriasis using dead cells of Mycobacterium vaccae'
[patent_app_type] => 1
[patent_app_number] => 8/441980
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1641
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/833/05833996.pdf
[firstpage_image] =>[orig_patent_app_number] => 441980
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441980 | Treatment of psoriasis using dead cells of Mycobacterium vaccae | May 15, 1995 | Issued |
Array
(
[id] => 3662839
[patent_doc_number] => 05599545
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Mycobacterium as adjuvant for antigens'
[patent_app_type] => 1
[patent_app_number] => 8/441785
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2379
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599545.pdf
[firstpage_image] =>[orig_patent_app_number] => 441785
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441785 | Mycobacterium as adjuvant for antigens | May 15, 1995 | Issued |